Literature DB >> 17657850

Unexpected anterograde amnesia associated with Buscopan used as a predmedication for endocscopy.

Hyuk Lee1, Hee Jung Son, Poong-Lyul Rhee, Jae J Kim, Jong Chul Rhee.   

Abstract

It has been known that peripheral adverse event is caused by peripheral antimuscarinic action, from hyoscine butylbromide (Buscopan; Boehringer Ingelheim, Germany) used as a premedication for endoscopy. However, symptoms or signs associated with the central nervous system are rarely reported in the field of anesthesiology and peripartum labor. This central anticholinergic syndrome is likely caused by blockade of muscarinic cholinergic receptors in the central nervous system. There is no report on Buscopan-induced central anticholinergic syndrome in endoscopy room so far. Three middle-aged females unexpectedly suffered from anterograde amnesia after intramuscular injection of hyoscine butylbromide as an antispasmodic premedication for endoscopy at our endoscopy unit in the Health Promotion Center.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17657850      PMCID: PMC4611228          DOI: 10.3748/wjg.v13.i28.3895

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  6 in total

Review 1.  Role of cholinergic system on the construction of memories: taste memory encoding.

Authors:  María Isabel Miranda; Guillaume Ferreira; Leticia Ramírez-Lugo; Federico Bermúdez-Rattoni
Journal:  Neurobiol Learn Mem       Date:  2003-11       Impact factor: 2.877

2.  Physostigmine: going ... going ... gone? Two cases of central anticholinergic syndrome following anaesthesia and its treatment with physostigmine.

Authors:  B Martin; P R Howell
Journal:  Eur J Anaesthesiol       Date:  1997-07       Impact factor: 4.330

Review 3.  Pharmacokinetics and pharmacodynamics in clinical use of scopolamine.

Authors:  Ulf D Renner; Reinhard Oertel; Wilhelm Kirch
Journal:  Ther Drug Monit       Date:  2005-10       Impact factor: 3.681

4.  Randomized, double-blinded, placebo-controlled trial of intravenously administered hyoscine N-butyl bromide in patients undergoing colonoscopy with patient-controlled sedation.

Authors:  Lik-man Mui; Enders K W Ng; Kang-chung Chan; Calvin S H Ng; Alex C M Au Yeung; Simon K C Chan; Simon K H Wong; S C Sydney Chung
Journal:  Gastrointest Endosc       Date:  2004-01       Impact factor: 9.427

5.  Presumed central anticholinergic syndrome from inadvertent intravenous hyoscine hydrobromide (scopolamine) injection.

Authors:  J Wilden; D Rapeport
Journal:  Anaesth Intensive Care       Date:  2004-06       Impact factor: 1.669

Review 6.  Pharmacokinetics and related pharmacodynamics of anticholinergic drugs.

Authors:  T Ali-Melkkilä; J Kanto; E Iisalo
Journal:  Acta Anaesthesiol Scand       Date:  1993-10       Impact factor: 2.105

  6 in total
  1 in total

1.  Vascular action as the primary mechanism of cognitive effects of cholinergic, CNS-acting drugs, a rat phMRI BOLD study.

Authors:  Pál Kocsis; István Gyertyán; János Éles; Judit Laszy; Nikolett Hegedűs; Dávid Gajári; Levente Deli; Zsófia Pozsgay; Szabolcs Dávid; Károly Tihanyi
Journal:  J Cereb Blood Flow Metab       Date:  2014-03-19       Impact factor: 6.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.